Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H18O |
Molecular Weight | 178.2707 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=CC=CC(C(C)C)=C1O
InChI
InChIKey=OLBCVFGFOZPWHH-UHFFFAOYSA-N
InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3
Molecular Formula | C12H18O |
Molecular Weight | 178.2707 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:59:02 UTC 2023
by
admin
on
Sat Dec 16 17:59:02 UTC 2023
|
Record UNII |
YI7VU623SF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
CFR |
21 CFR 522.2005
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
WHO-ATC |
N01AX10
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
NDF-RT |
N0000175681
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
NDF-RT |
N0000175975
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
WHO-VATC |
QN01AX10
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
LIVERTOX |
NBK547909
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
1.1.2
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m9217
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | Merck Index | ||
|
5073
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
DB00818
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
C29384
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
7123
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
44915
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
DTXSID6023523
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
YI7VU623SF
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
YI7VU623SF
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
2302
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
4943
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
100000091539
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
D015742
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
Propofol
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
CHEMBL526
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
5464
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
U-89
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
2078-54-8
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
SUB10116MIG
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
8782
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | RxNorm | ||
|
218-206-6
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
1572503
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY | |||
|
PROPOFOL
Created by
admin on Sat Dec 16 17:59:03 UTC 2023 , Edited by admin on Sat Dec 16 17:59:03 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.25
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
test 1
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 5.0
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
test 2
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
Limit of propofol related compound A?[note?This test is to be performed in conjunction with Related compounds Test 1. ]
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
test 2
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
Limit of propofol related compound B
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
After a 10-day infusion PHARMACOKINETIC |
|
||